The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of combination therapy with gemcitabine
and docetaxelin in patients with locally advanced or metastatic pancreatic or biliary
adenocarcinoma.